Key Statistics
Market Cap$49.21M
P/E RatioN/A
Div. Yield—
EPS (TTM)-$58.66
52W High$16.52
52W Low$6.47
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
Employees76
Price Performance
1 Week+2.28%
3 Month-10.13%
1 Year-13.19%
FinancialsAnnual · QuiverQuant
Revenue$0
Assets$60.93M
Liabilities$24.10M
Net Income$76.40M loss
About
Xilio Therapeutics, Inc., a biotechnology company, designs immunotherapies to improve the immune systems of cancer patients. The company is headquartered in Waltham, Massachusetts.
WebullFree stocks
Advanced charting, extended hours trading, and free stock for new accounts.
Analyze XLO with professional charts— Free to start
Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.